Our Mission
Healing people from within
– right where they are
At Ensoma, we are expanding the reach of the curative power of genomic medicine and cell therapy by pioneering a targeted, next-generation in vivo approach that enables delivery in virtually any setting.
Every person, no matter where they are, should have access to innovative technologies that are changing the way we treat disease – even in outpatient settings.
The foundation of our next-generation approach is our ingeniously engineered Engenious™ vectors, which allow us to deliver gene modification technologies directly to stem cells or the various cell types that arise from these cells, such as T cells, B cells and myeloid cells, without the need for stem cell collection or prior conditioning (e.g. chemotherapy), which can be toxic to patients. Our genomic medicines and cell therapies can be delivered in a simple, single injection.
Ensoma is poised to bring life-changing therapies to people everywhere, including areas where access to sophisticated healthcare systems or specialty centers may be limited.
